
Experimental vaccine for common cancer shows potential in clinical trial
Fox News
A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study co-author Dr. Vinod Balachandran talks about the impact on future cancer care.
Results from the phase 1 clinical trial, published in the journal Nature, revealed that the vaccine triggered an immune response in a small patient group. "The ability to trigger a robust, long-lasting immune response is a requisite feature for any cancer vaccine." "If you can do this in pancreatic cancer, theoretically you may be able to develop therapeutic vaccines for other cancer types." Angelica Stabile is a lifestyle reporter for Fox News Digital.
This immune-cell activation persisted for nearly four years after treatment, the release stated.

Pizza before tomatoes? Ancient Rome's version of America's favorite food looked nothing like today's
Ancient Rome pizza at Hungary restaurant features no tomatoes or mozzarella, using garum fish sauce and olive paste. Neverland Pizzeria's dish is limited-edition.












